• Morin: Applied Protocols and Innovations in Disease Modeling

  2026-06-16

  Morin, a bioactive 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one, enables advanced disease modeling and energy metabolism research with superior specificity and analytical versatility. Explore actionable workflows and troubleshooting strategies that unlock Morin's full potential as a dual-function modulator and fluorescent probe.

• Bioluminescent Probes for Immunoproteasome: Synthesis & Insi

  2026-06-15

  Loy and Trader introduce a synthetic protocol for a bioluminescent probe selective for the immunoproteasome (iCP), enabling direct monitoring of iCP activity in cellular and tissue assays. This innovation provides a valuable tool for studying iCP involvement in disease and for screening small-molecule modulators, addressing longstanding limitations of previous probes.

• Canagliflozin (SKU A8333): Reliable SGLT2 Inhibitor for Rena

  2026-06-15

  This article addresses real-world experimental challenges in cell viability and mitochondrial assays, demonstrating how Canagliflozin (SKU A8333) provides reproducible, data-driven solutions for glucose metabolism and kidney disease modeling. Leveraging authoritative literature and workflow optimization, it guides researchers on selecting and applying this potent SGLT2 inhibitor in metabolic and renal studies.

• Scalable Bioreactor Platform for Therapeutic MSC-EV Producti

  2026-06-14

  Gong et al. introduce a robust, scalable platform for producing mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) using extended pluripotent stem cells (EPSCs) and bioreactor technology. This standardized approach overcomes key barriers of donor variability and manufacturing scale, enabling consistent EVs with therapeutic potential for regenerative medicine.

• Targeting CYP2B6 in Glioblastoma via ATF5 Peptide Downregula

  2026-06-13

  This study demonstrates that a cell-penetrating dominant-negative ATF5 peptide effectively downregulates CYP2B6 in glioblastoma cells, uncovering a regulatory axis with implications for precision oncology drug dosing. The findings highlight a novel strategy to modulate drug metabolism in tumor cells, potentially improving therapeutic efficacy and safety.

• Anlotinib Hydrochloride in IADSRCT: Case Evidence and Resear

  2026-06-12

  The referenced case report documents the first successful use of anlotinib hydrochloride, a multi-target tyrosine kinase inhibitor, in treating metastatic intra-abdominal desmoplastic small round cell tumor (IADSRCT). This work highlights both the clinical potential and the mechanistic rationale for targeting angiogenic and proliferative pathways in rare, aggressive sarcomas.

• PK/PD Analysis of Gamithromycin in Murine Pasteurella Infect

  2026-06-12

  This study rigorously defines pharmacokinetic and pharmacodynamic (PK/PD) indices for Gamithromycin in a neutropenic murine lung infection model of Pasteurella multocida. By linking unbound drug exposure to antibacterial efficacy, the research provides actionable parameters for optimized dosing in veterinary respiratory disease research.

• Tigecycline in Antimicrobial Research: Protocols and Optimiz

  2026-06-11

  Tigecycline's unique glycylcycline scaffold empowers labs to dissect multidrug-resistant mechanisms and optimize infection models with precision. This guide translates new resistance gene insights into practical protocols and troubleshooting strategies—making APExBIO’s Tigecycline an essential tool for advanced antimicrobial studies.

• Ionizing Radiation Alters Neural Differentiation via PI3K-ST

  2026-06-11

  This study demonstrates that ionizing radiation (IR) induces aberrant neuronal differentiation in C17.2 mouse neural stem-like cells through coordinated PI3K-STAT3-mGluR1 and PI3K-p53 signaling. The findings highlight the complex molecular pathways underlying radiation-induced changes in neurogenesis, with implications for understanding brain dysfunction following radiotherapy.

• Actinomycin D: Applied Workflows for Transcriptional Stress

  2026-06-10

  Actinomycin D (ActD) is the gold-standard transcriptional inhibitor empowering researchers to dissect cellular stress, apoptosis, and mRNA dynamics in complex cancer models. This article delivers hands-on workflow enhancements, troubleshooting advice, and strategic insights for leveraging APExBIO’s trusted Actinomycin D in cutting-edge experimental contexts.

• L-Ornithine in CNS Toxicity Models: Protocols & Workflow Ins

  2026-06-10

  L-Ornithine, a vital urea cycle intermediate, is transforming advanced CNS toxicity and metabolic enzyme assays by enabling precise modeling of liver–brain axis dysfunction. This guide delivers actionable, literature-backed protocols and troubleshooting strategies for researchers using high-purity L-Ornithine from APExBIO.

• Ac-YVAD-CMK: Selective Caspase-1 Inhibition in Inflammation

  2026-06-09

  Ac-YVAD-CMK (N-Ac-Tyr-Val-Ala-Asp-CMK) is a potent, irreversible caspase-1 inhibitor that blocks the maturation of IL-1β and IL-18. This product enables precise dissection of pyroptosis and inflammatory cytokine release, supporting high-clarity research in cell death and immunology.

• Plasmid-Mediated Carbapenemase Genes in CREC: Dynamics in Gu

  2026-06-09

  This study systematically characterizes carbapenemase-encoding gene (CEG) prevalence and transfer in carbapenem-resistant Enterobacter cloacae (CREC) across eight teaching hospitals in Guangdong, China during the COVID-19 pandemic. Key findings reveal dominant plasmid-borne blaNDM-1, extensive multidrug resistance, and highly efficient horizontal gene transfer, highlighting urgent challenges for infection control and antimicrobial research.

• Panobinostat (LBH589): Applied Protocols for Apoptosis Resea

  2026-06-08

  Panobinostat (LBH589) is redefining experimental standards in apoptosis and epigenetic regulation research by enabling precision modulation of HDAC activity and integration with advanced cell death pathway assays. This article translates the latest mechanistic breakthroughs into robust workflows, troubleshooting, and comparative insights for cancer and resistance model systems.

• O-GlcNAcylation, HUWE1, and Ferroptosis in Preeclampsia Plac

  2026-06-08

  This study uncovers how O-GlcNAc modification stabilizes HUWE1 to promote TfR1 ubiquitination, limiting iron uptake and ferroptosis in trophoblasts and influencing syncytialization in preeclampsia. These insights reveal a critical regulatory axis, highlighting new opportunities for placental biology and ferroptosis research.

8496 records 14/567 page Previous Next First page 上5页 1112131415 下5页 Last page